Form D Explorer

Form C-AR — iMetabolic Biopharma Corporation

0001957114-26-000001 · filed 2026-05-06

Offering

Target
Maximum
Security type
Price per security
Deadline
Oversubscription

Issuer

CIK
1957114
Entity
Corporation
Jurisdiction
NV
Address
275 N Gateway Dr, Suite 104
Phoenix, AZ 85034
Phone

Most recent fiscal year financials

Total assets
$27,787
Cash
Short-term debt
$65,378
Long-term debt
$557,779
Revenues
$137,329
COGS
Taxes paid
Net income
$-99,746

View original on SEC EDGAR.